(Q51585335)

English

Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitor.

scientific article published in October 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitor. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

bioavailability

1 reference

based on heuristic

inferred from title

author name string

Radulovic LL

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

Cilla DD

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

Posvar EL

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

Sedman AJ

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

Whitfield LR

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

publication date

1 October 1995

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

35

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

10

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

990-994

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04015.X

21 January 2018

Clinical pharmacokinetics and practical applications of simvastatin

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04015.X

21 January 2018

Clinical implications of the biopharmaceutical properties of fluvastatin

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04015.X

21 January 2018

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04015.X

21 January 2018

Identifiers

10.1002/J.1552-4604.1995.TB04015.X

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/8568017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51585335&oldid=2132217644"